Skip to content

Effects of brain training in Huntington’s disease

Efficacy and neural mechanisms of computerised cognitive training in Huntington’s disease: A randomised controlled trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12622000908730
Enrollment
30
Registered
2022-06-27
Start date
2022-07-19
Completion date
2024-01-24
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Huntington’s disease (HD) involves progressive decline in cognitive function, often beginning many years prior to clinical diagnosis, and drastically affects quality of life. Further, there are currently no effective treatments for cognitive decline in HD. Cognitive training has been found to be effective in improving cognitive function in other populations, but has not been thoroughly investigated in HD. This study aims to examine the effects of cognitive training on cognitive and clinical outcomes in people with HD, as well as its effects on brain function. This will be done by randomly allocating participants to either an intervention group or a control group. The intervention group will complete cognitive training over 3 months, whereas the control group will receive a monthly newsletter on lifestyle factors associated with cognitive function and will be provided access to the training program after the study period. It is hypothesised that compared to the control group, participants in the intervention group will have: (1) improved cognitive function; (2) improved neuropsychiatric symptoms; (3) improved subjective cognition; (4) improved health-related quality of life; (5) increased connectivity in brain networks involved in cognitive tasks; and (6) increased connectivity in brain networks during rest, after the study period.

Interventions

The intervention consists of computerised cognitive training, using the BrainHQ platform. BrainHQ involves a suite of online exercises targeting various cognitive functions, including processing speed, attention, working memory and executive functions. The training will be adaptive, i.e., the difficulty level will be adjusted according to participant performance and progress. Exercises will involve short games requiring a response using mouse or keyboard, such as reproducing a sequence of digits

The intervention consists of computerised cognitive training, using the BrainHQ platform. BrainHQ involves a suite of online exercises targeting various cognitive functions, including processing speed, attention, working memory and executive functions. The training will be adaptive, i.e., the difficulty level will be adjusted according to participant performance and progress. Exercises will involve short games requiring a response using mouse or keyboard, such as reproducing a sequence of digits presented in moving circles. Training will be administered on the participants’ personal computer, within their own homes. Participants will access the training via the BrainHQ website. Participants will be required to complete two 1-hour sessions of training per week, over 12 weeks. One session each week will be completed individually, without supervision, while another session will be supervised using a video conference software, and in a group format if scheduling allows. Supervision will be conducted by a student researcher trained in administering the cognitive training. Participant adherence will be assessed according to the activity logs in BrainHQ, which automatically records the number of hours of training completed. Fidelity will be maintained through weekly phone calls by the student researcher to provide feedback on progress and increase motivation to complete the training. Barriers to adherence will be discussed and troubleshooted.

Sponsors

Monash University
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Inclusion criteria include: (a) Genetically positive for Huntington’s disease (HD) (b) Premanifest disease or early-stage manifest disease (total functional capacity [TFC] = 7-13) (c) 18+ years of age (d) Access to computer with Internet connection

Exclusion criteria

Exclusion criteria include: (a) Absence of known genetic confirmation for HD (b) Late-stage disease (TFC < 7) (c) Under 18 years of age (d) Diagnosis of any major neurological or psychiatric condition other than HD (besides anxiety or depression), history of substance abuse or head injury (e) Severe depression and anxiety symptoms (score > 14 on either HADS subscale) (f) Unstable dose of medication for depression and anxiety in the last 6 months Additional exclusion criteria if undergoing MRI: (a) Left-handed (b) Currently pregnant (c) Other MRI contraindications

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 6, 2026